Delivery Order SPE2DB24D1205-SPE2DB25FCRAT

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,008.39 delivery order contract is for NAYZILAM 5 MG NASAL SPRAYS, with an ultimate completion date of April 26, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $1,008.39, is a delivery order for 4,564,389,901 units of the pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. The contract has no set-aside designation and is a firm fixed-price arrangement with an ultimate completion date of April 25, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of NAYZILAM 5 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $1,008.39 and an ultimate completion date of April 17, 2024. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.25, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,674.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NAYZILAM 5 MG NASAL SPRAYS to the U.S. government. The contract, valued at $1,344.52, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $1,324.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and has a completion date of April 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a $1,061.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of August 1, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.39 Firm Fixed Price delivery order is for the supply of NAYZILAM 5 MG nasal sprays, a medication used for the treatment of seizures. The contract has an ultimate completion date of April 5, 2023 and does not contain any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation, a $1,008.39 firm fixed price delivery order contract to supply 4564168540 units of the specialty pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCRAT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,132.54 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a completion date of October 24, 2024. The contract does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/22/25, 9:22 AM